Patent · US Active

Carbamate/urea derivatives

US9273026B2 · kind B2 · utility

2Cited by

1References

24Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Yves Auberson · Allschwil, CH
Mark G. Bock · Hatfield, US
Dario Braga · Bologna, IT
Marco Curzi · Bologna, IT
Stephanie Kay Dodd · Ayer, US
Stefano Luca Giaffreda · Bologna, IT
Hayang JIANG · Shanghai, CN
Piotr H. Karpinski · Lincoln Park, US
Thomas J. Troxler · Wahlen, CH
Tie-Lin Wang · Shanghai, CN
Xiaoyang Wang · Shanghai, CN
Xuechun Zhang · Hangzhou City, CN

Key dates

Filing date	Apr 14, 2015
Grant date	Mar 1, 2016
Priority date	—
Expiry date	Apr 14, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07B2200/13
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to compound of the formula Ior a salt thereof, wherein the substituents are as defined in the specification; to its preparation, to its use as medicament and to medicaments comprising it.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.